Stephen B Williams1, Jim C Hu. 1. Division of Urology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 20015, USA. swilliams22@partners.org
Abstract
OBJECTIVES: Salvage robotic assisted laparoscopic radical prostatectomy (SRALP) has now become a feasible alternative to open prostatectomy in experienced hands. Herein we review the urologic literature for the indications and outcomes of SRALP. METHODS: A comprehensive review of the peer reviewed literature was performed for reported cases of salvage robotic and open prostatectomy, with emphasis being on comparing oncologic outcomes. RESULTS: Salvage prostatectomy, whether open or robotic, is a viable alternative for treatment of recurrent, localized, non-metastatic prostate cancer after failed primary radiotherapy. Although few reports of salvage robotic prostatectomy have been published with limited long-term follow-up, initial oncologic results seem at least comparable to the salvage open prostatectomy series. SRALP should be performed by centers with a dedicated and well experienced robotic urologic oncology program. CONCLUSIONS: SRALP is a feasible surgical treatment option for patients with recurrence after primary radiotherapy with preliminary oncologic outcomes comparable to the open approach. Further long-term follow-up is needed to validate these results.
OBJECTIVES: Salvage robotic assisted laparoscopic radical prostatectomy (SRALP) has now become a feasible alternative to open prostatectomy in experienced hands. Herein we review the urologic literature for the indications and outcomes of SRALP. METHODS: A comprehensive review of the peer reviewed literature was performed for reported cases of salvage robotic and open prostatectomy, with emphasis being on comparing oncologic outcomes. RESULTS: Salvage prostatectomy, whether open or robotic, is a viable alternative for treatment of recurrent, localized, non-metastatic prostate cancer after failed primary radiotherapy. Although few reports of salvage robotic prostatectomy have been published with limited long-term follow-up, initial oncologic results seem at least comparable to the salvage open prostatectomy series. SRALP should be performed by centers with a dedicated and well experienced robotic urologic oncology program. CONCLUSIONS: SRALP is a feasible surgical treatment option for patients with recurrence after primary radiotherapy with preliminary oncologic outcomes comparable to the open approach. Further long-term follow-up is needed to validate these results.
Authors: Ronald S Boris; Akshay Bhandari; L Spencer Krane; Daniel Eun; Sanjeev Kaul; James O Peabody Journal: BJU Int Date: 2008-12-02 Impact factor: 5.588
Authors: Jim C Hu; Xiangmei Gu; Stuart R Lipsitz; Michael J Barry; Anthony V D'Amico; Aaron C Weinberg; Nancy L Keating Journal: JAMA Date: 2009-10-14 Impact factor: 56.272
Authors: Christopher J Kane; Christopher L Amling; Peter A S Johnstone; Nali Pak; Raymond S Lance; J Brantley Thrasher; John P Foley; Robert H Riffenburgh; Judd W Moul Journal: Urology Date: 2003-03 Impact factor: 2.649
Authors: Jonathan A Eandi; Brian A Link; Rebecca A Nelson; David Y Josephson; Clayton Lau; Mark H Kawachi; Timothy G Wilson Journal: J Urol Date: 2010-01 Impact factor: 7.450
Authors: Piyush K Agarwal; Natalia Sadetsky; Badrinath R Konety; Martin I Resnick; Peter R Carroll Journal: Cancer Date: 2008-01-15 Impact factor: 6.860